OpenNashEarnings

HCA Healthcare (HCA) · Health Care

HCA Healthcare Q2 2026 earnings: summary, key numbers & outlook

Results filed 14 Jul 2026 · Quarter ended 30 Jun 2026

Press release ↗Investor relations ↗

Summaries and transcripts are machine-generated and can contain errors.

In brief

HCA Healthcare absorbed a wave of exchange coverage losses that pushed patients to uninsured status, even as ER and admissions volumes grew and Florida's new Medicaid directed payment program was approved.

Demand at HCA's hospitals stayed healthy: same facility admissions rose 2.5 percent and emergency room visits rose 3.6 percent. But the patient mix worsened, as people who lost health insurance exchange coverage largely became uninsured. Surgical volumes fell, with inpatient surgeries down 2.3 percent and outpatient surgeries down 3.4 percent. The Centers for Medicare and Medicaid Services approved a Florida state directed payment program, giving a Medicaid supplemental payment benefit.

Management is steering toward its plan to digitize and grow its healthcare networks, backed by capital spending of $5.0 billion to $5.5 billion, which is unchanged. It says it is gaining market share and that its Valesco acquisition gave it control of many hospital-based services. The main tension is policy: exchange losses are now expected to be larger, and future Medicaid payment approvals are excluded from guidance, so coverage and reimbursement rules remain outside management's control.

No call transcript for this quarter, so this summary also draws on: AllMind AI ↗.

Key numbers

Revenue (preliminary) · GAAP
$20.230 billion

compared to $18.605 billion in the second quarter of 2025

Net income attributable to HCA Healthcare (preliminary) · GAAP
$1.699 billion

compared to $1.653 billion in the second quarter of 2025

Diluted EPS (preliminary) · GAAP
$7.62

compared to $6.83 in the second quarter of 2025

Diluted EPS, as adjusted (preliminary) · non-GAAP
$7.59

compared to $6.84 in the second quarter of 2025

Adjusted EBITDA (preliminary) · non-GAAP
$4.027 billion

compared to $3.849 billion in the second quarter of 2025

Segment or metricValueChange
Same facility admissions2.5 percentincrease versus the prior year period
Same facility equivalent admissions2.7 percentincrease versus the prior year period
Same facility emergency room visits3.6 percentincrease versus the prior year period
Same facility inpatient surgeries2.3 percentdecline versus the prior year period
Same facility outpatient surgeries3.4 percentdecline versus the prior year period
Where each number comes from
  • Revenue (preliminary): “HCA anticipates revenues in the second quarter of 2026 to approximate $20.230 billion, compared to $18.605 billion in the second quarter of 2025.”
  • Net income attributable to HCA Healthcare (preliminary): “Net income attributable to HCA Healthcare, Inc. is expected to approximate $1.699 billion, or $7.62 per diluted share, compared to $1.653 billion, or $6.83 per diluted share, in the second quarter of 2025.”
  • Diluted EPS (preliminary): “Net income attributable to HCA Healthcare, Inc. is expected to approximate $1.699 billion, or $7.62 per diluted share, compared to $1.653 billion, or $6.83 per diluted share, in the second quarter of 2025.”
  • Diluted EPS, as adjusted (preliminary): “Net income attributable to HCA Healthcare, Inc., as adjusted (a) | $7.59 | $6.84 Shares used in computing diluted earnings per share (millions) | 222.828 | 241.911”
  • Adjusted EBITDA (preliminary): “For the second quarter of 2026, Adjusted EBITDA is expected to approximate $4.027 billion, compared to $3.849 billion in the second quarter of 2025.”
  • Same facility admissions: “Same facility admissions increased 2.5 percent and same facility equivalent admissions increased 2.7 percent in the second quarter of 2026 compared to the prior year period.”
  • Same facility equivalent admissions: “Same facility admissions increased 2.5 percent and same facility equivalent admissions increased 2.7 percent in the second quarter of 2026 compared to the prior year period.”
  • Same facility emergency room visits: “Same facility emergency room visits increased 3.6 percent in the second quarter of 2026 compared to the prior year period.”
  • Same facility inpatient surgeries: “Same facility inpatient surgeries declined 2.3 percent, and same facility outpatient surgeries declined 3.4 percent in the second quarter of 2026 compared to the same period of 2025.”
  • Same facility outpatient surgeries: “Same facility inpatient surgeries declined 2.3 percent, and same facility outpatient surgeries declined 3.4 percent in the second quarter of 2026 compared to the same period of 2025.”

Copied from the press release ↗ and other documents in the SEC filing ↗. A figure is published only if its sentence is in those documents.

From the filingQ2 2026vs year agovs last quarter
Revenue$20.2B+8.7%+5.9%
Net income$1.7B+2.8%+4.9%
Diluted EPS$7.62+11.6%+6.6%
Free cash flow$1.1B−63.6%+23.4%

Calculated by code from XBRL, not by the model.

Outlook

MetricPeriodOutlook
Revenues2026$77.000 to $79.500 billion
Net income attributable to HCA Healthcare2026$6.300 to $6.700 billion
Adjusted EBITDA2026$15.400 to $16.100 billion
Diluted EPS2026$28.70 to $30.50 per diluted share
Capital expenditures, excluding acquisitions2026$5.0 billion to $5.5 billion
Health insurance exchange payer mix impact on income before income taxes2026($1.000) to ($1.200) billion
Incremental net benefit from Medicaid Supplemental Payment Programs2026$300 to $500 million

Key takeaways

  1. Exchange coverage losses are shifting patients to uninsured

    Patients who lost health insurance exchange coverage drove an increase in uninsured volume, which HCA estimates cost about $400 million of pre-tax income in the quarter. Management raised its full-year exchange impact estimate to ($1.000) to ($1.200) billion from ($600) to ($900) million.

  2. Emergency room and admissions volumes kept growing

    Same facility admissions rose 2.5 percent, equivalent admissions 2.7 percent and ER visits 3.6 percent. Demand for hospital care is holding up even as the payer mix deteriorates.

  3. Surgical volumes declined, creating a service mix shift

    Same facility inpatient surgeries fell 2.3 percent and outpatient surgeries fell 3.4 percent. HCA cites this as a secondary mix headwind, since surgical services are a key part of its care portfolio.

  4. Florida directed payment approval reset Medicaid supplemental outlook

    CMS approved a state directed payment program in Florida during the quarter, covering October 1, 2024 through June 30, 2026. HCA now expects a Medicaid Supplemental Payment Programs benefit of $300 to $500 million for 2026, versus a prior estimate of ($50) to ($250) million.

  5. Capacity investment and Valesco acquisition support growth strategy

    HCA's capital spending plan of $5.0 billion to $5.5 billion is unchanged, and it points to its network digitization strategy. It also says the Valesco acquisition gave it control of many hospital-based services and that it is gaining market share in many markets.

Charts

Revenue$20.2B+8.7% y/yQ2 2026
Q4 2024: $18.3B (worked out from the annual figure)Q4 ’24$18.3BQ1 2025: $18.3BQ1 ’25$18.3BQ2 2025: $18.6BQ2 ’25$18.6BQ3 2025: $19.2BQ3 ’25$19.2BQ4 2025: $19.5B (worked out from the annual figure)Q4 ’25$19.5BQ1 2026: $19.1BQ1 ’26$19.1BQ2 2026: $20.2BQ2 ’26$20.2BQ3 2026: $19.8BQ3 ’26$19.8B

Fourth quarter worked out from the annual figure.

Data
Q4 2024$18.3B *
Q1 2025$18.3B
Q2 2025$18.6B
Q3 2025$19.2B
Q4 2025$19.5B *
Q1 2026$19.1B
Q2 2026$20.2B
Q3 2026$19.8B
Diluted EPS (GAAP)$7.62+11.6% y/yQ2 2026
Q1 2025: $6.45Q1 ’25$6.45Q2 2025: $6.83Q2 ’25$6.83Q3 2025: $6.96Q3 ’25$6.96Q1 2026: $7.15Q1 ’26$7.15Q2 2026: $7.62Q2 ’26$7.62Q3 2026: $7.27Q3 ’26$7.27
Data
Q1 2025$6.45
Q2 2025$6.83
Q3 2025$6.96
Q1 2026$7.15
Q2 2026$7.62
Q3 2026$7.27

Fourth-quarter EPS appears once the press release is read; filings report it only for the full year.

Free cash flow$1.1B−63.6% y/yQ2 2026
Q4 2024: $1.3BQ4 ’24$1.3BQ1 2025: $660.0MQ1 ’25$660.0MQ2 2025: $3.0BQ2 ’25$3.0BQ3 2025: $3.1BQ3 ’25$3.1BQ4 2025: $870.0MQ4 ’25$870.0MQ1 2026: $895.0MQ1 ’26$895.0MQ2 2026: $1.1BQ2 ’26$1.1BQ3 2026: $3.1BQ3 ’26$3.1B
Data
Q4 2024$1.3B
Q1 2025$660.0M
Q2 2025$3.0B
Q3 2025$3.1B
Q4 2025$870.0M
Q1 2026$895.0M
Q2 2026$1.1B
Q3 2026$3.1B

Operating cash flow minus capital expenditure, from cash flow statements.

Questions

What drove HCA's payer mix problem this quarter?

An increase in uninsured volume, mainly from patients who lost coverage on the health insurance exchanges. HCA estimates this cost about $400 million of pre-tax income in the quarter and now expects a $1.000 to $1.200 billion hit for 2026.

How did patient volumes trend at HCA hospitals?

Demand grew in admissions, with same facility admissions up 2.5 percent and ER visits up 3.6 percent. Surgeries declined, with inpatient down 2.3 percent and outpatient down 3.4 percent.

What happened with Medicaid supplemental payments?

CMS approved a Florida state directed payment program during the quarter, so HCA recognized about $400 million of incremental net benefit covering October 1, 2024 through June 30, 2026. Guidance excludes any future approvals of this kind.

Is HCA changing its investment plans or strategy?

No. Its 2026 capital expenditure estimate of $5.0 billion to $5.5 billion is unchanged, and CEO Sam Hazen says it will keep executing its strategic plan to digitize and grow its healthcare networks.

What is HCA saying about its competitive position?

Management says it believes it is gaining market share in many of its markets. It also says its Valesco acquisition gave it control of many of its hospitals' hospital-based services.

Documents

From HCA Healthcare investor relations

SEC filing